Science Explorer Back to mapMap
Discussion
Topic · Oncology

Cancer Risks and Factors

Cancer Risks and Factors is a research topic within Oncology. Science Explorer counts 28k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the relationship between obesity, adiposity, and body mass index with cancer risk, prognosis, and treatment outcomes. It covers various aspects such as breast cancer, pregnancy-associated breast cancer, metabolic syndrome, hormonal influences, chemotherapy effects, and survival rates in relation to obesity.

  • Obesity
  • Cancer
  • Body Mass Index
  • Breast Cancer
  • Pregnancy
  • Adiposity
  • Metabolic Syndrome
  • Chemotherapy
  • Hormones
  • Survival
Research works
28k
fractional, since 1950
In the world top 10%
2.8k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+10%
the tick is no change
Largest producer
United States
40% of the 10 largest, 2022-now
Cancer Risks and Factors

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cancer Risks and Factors research?

By volume, the United States and China publish the most (1.5k and 757 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.5k works
  2. 2 China 757 works
  3. 3 India 270 works
  4. 4 Brazil 269 works
  5. 5 United Kingdom 212 works
  6. 6 Italy 196 works
  7. 7 South Korea 157 works
  8. 8 Germany 150 works
  9. 9 Japan 137 works
  10. 10 France 136 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.1%China: 19.9%India: 7.1%Brazil: 7.0%6 others listed: 25.9%40%largest
United States1,530 · 40.1%China757 · 19.9%India270 · 7.1%Brazil269 · 7.0%6 others listed989 · 25.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cancer Risks and Factors research?

By volume in 2022-now, Harvard University publishes the most Cancer Risks and Factors research, followed by University of North Carolina at Chapel Hill and National Institutes of Health.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 70 works
  2. 2 University of North Carolina at Chapel HillUnited States 57 works
  3. 3 National Institutes of HealthUnited States 38 works
  4. 4 The University of Texas MD Anderson Cancer CenterUnited States 33 works
  5. 5 Mayo ClinicUnited States 27 works
  6. 6 Capital Medical UniversityChina 25 works
  7. 7 Sichuan UniversityChina 24 works
  8. 8 University of TorontoCanada 24 works
  9. 9 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 23 works
  10. 10 All India Institute of Medical SciencesIndia 23 works

Who are the leading researchers in Cancer Risks and Factors?

The most-cited researchers publishing on Cancer Risks and Factors include Douglas G. Altman, Ahmedin Jemal and Christopher J L Murray.

  1. 1 Douglas G. Altman United Kingdom 862k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Christopher J L Murray United States 583k citations
  4. 4 Rebecca L. Siegel United States 582k citations
  5. 5 Freddie Bray France 550k citations
  6. 6 Jacques Ferlay France 486k citations
  7. 7 Theo Vos United States 439k citations
  8. 8 George Davey Smith United Kingdom 435k citations
  9. 9 Ali H. Mokdad United States 429k citations
  10. 10 Walter Churchill Willett United States 411k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cancer Risks and Factors?

The most cited paper in Cancer Risks and Factors is "Cancer statistics, 2022" (Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al., 2022), with 18,352 citations. Next come "Cancer Statistics, 2009" (9,734) and "Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults" (7,770).

Most cited papers
#PaperReleasedCitations
1 Cancer statistics, 2022 Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians Open access 2022 18,352
2 Cancer Statistics, 2009 Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians Open access 27 May 2009 9,734
3 Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults Eugenia E. Calle, Carmen Rodríguez, Kimberly A Walker-Thurmond et al. · New England Journal of Medicine Open access 23 Apr 2003 7,770
4 Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 Jacques Ferlay, Eva Steliarova‐Foucher, Joannie Lortet‐Tieulent et al. · European Journal of Cancer Open access 25 Feb 2013 5,286
5 Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Andrew G. Renehan, Margaret Tyson, Matthias Egger et al. · The Lancet Review Feb 2008 5,283
All 100 most cited papers, with filters and sorting

Where is Cancer Risks and Factors research done?

The largest centres of Cancer Risks and Factors research in 2022-now are Beijing (China), Seoul (South Korea), New York (United States) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Chapel Hill.

Largest cities, 2022-now

  1. 1 BeijingChina 109 works
  2. 2 SeoulSouth Korea 96 works
  3. 3 New YorkUnited States 80 works
  4. 4 BostonUnited States 67 works
  5. 5 TehranIran 61 works
  6. 6 São PauloBrazil 61 works
  7. 7 LondonUnited Kingdom 60 works
  8. 8 Chapel HillUnited States 54 works
  9. 9 ShanghaiChina 51 works
  10. 10 HoustonUnited States 50 works

Where it is the local speciality

  1. Chapel HillUS · 54.1 works5.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Cancer Risks and Factors than the world average.

See Cancer Risks and Factors on the map

Where is the best place to study Cancer Risks and Factors?

Among universities, judged by research, Harvard University, Chinese Academy of Medical Sciences & Peking Union Medical College and Karolinska Institutet score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.09%fractional works in this field (log) →share of work in the world top 10% →Chinese Academy of M…University of Edinbu…Harvard UniversityKarolinska Institutet
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 78.717.7%4.3×70 -11.8%
2Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 69.529.8%4.3×24 +3.9%
3Karolinska InstitutetSweden 63.812.5%7.8×23 +3.8%
4University of EdinburghUnited Kingdom 57.524.5%1.8×8 +29.0%
5Heidelberg UniversityGermany 57.017.4%3.6×14 +54.2%
6Yale UniversityUnited States 55.817.5%3.0×17 +24.7%
7Capital Medical UniversityChina 55.115.9%4.5×25 +106.6%
8Huazhong University of Science and TechnologyChina 54.820.4%1.5×14 +113.5%
9University of MiamiUnited States 54.612.7%5.8×19 +68.6%
10University of OxfordUnited Kingdom 54.622.5%1.5×11 -17.7%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cancer Risks and Factors, country by country

Is Cancer Risks and Factors research growing?

Output in 2022-2025 was 10% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Cancer Risks and Factors.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cancer Risks and Factors as a percentage of every work published that year, 0.023% in 2024.

still counting0.010%0.020%0.030%Cancer Risks and Factors0.025% in 202519801990200020102020

Fractional works of Cancer Risks and Factors over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cancer Risks and Factors10.3% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cancer Risks and Factors. Posts are plain text and can be reported.